We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$867B
AUM Growth
-$1.1B
Cap. Flow
-$19.4B
Cap. Flow %
-2.24%
Top 10 Hldgs %
35.42%
Holding
3,110
New
92
Increased
1,805
Reduced
946
Closed
96

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.81B
2
BA icon
Boeing
BA
+$1.68B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.33B
4
APH icon
Amphenol
APH
+$1.11B
5
CME icon
CME Group
CME
+$902M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.65B
2
AMD icon
Advanced Micro Devices
AMD
+$2.51B
3
UNH icon
UnitedHealth
UNH
+$2.06B
4
UBER icon
Uber
UBER
+$1.84B
5
ADBE icon
Adobe
ADBE
+$1.44B

Sector Composition

Rank Sector Weight
1 Technology 33.21%
2 Healthcare 12.77%
3 Consumer Discretionary 11.71%
4 Financials 11.15%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRUS
776
DELISTED
Merus
MRUS
$47M 0.01%
1,116,820
-165,160
-13% -$7.93M
WEC icon
777
WEC Energy
WEC
$35.9B
$46.8M 0.01%
498,080
+5,785
+1% +$561K
BTSG icon
778
BrightSpring Health Services
BTSG
$11.9B
$46M 0.01%
2,698,629
+328,977
+14% +$5.69M
MKC icon
779
McCormick & Company Non-Voting
MKC
$14.6B
$45.8M 0.01%
601,322
+2,766
+0.5% +$217K
PLMR icon
780
Palomar
PLMR
$3.37B
$45.6M 0.01%
432,060
+122,057
+39% +$12.4M
NDAQ icon
781
Nasdaq
NDAQ
$54.6B
$45.5M 0.01%
589,035
+8,951
+2% +$692K
VERX icon
782
Vertex
VERX
$2.15B
$45.4M 0.01%
851,127
+596,077
+234% +$28.9M
GRMN
783
Garmin
GRMN
$60.2B
$45.3M 0.01%
219,743
+2,954
+1% +$579K
OPCH icon
784
Option Care Health
OPCH
$3.61B
$45.3M 0.01%
1,951,857
-706,136
-27% -$17.8M
TEVA icon
785
Teva Pharmaceuticals
TEVA
$42.6B
$45.2M 0.01%
2,049,388
+1,223,957
+148% +$22.3M
SPY icon
786
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$44.7M 0.01%
76,331
+26,655
+54% +$15.7M
HPQ icon
787
HP
HPQ
$28.6B
$44.6M 0.01%
1,368,263
-435,236
-24% -$15.6M
MRNA icon
788
Moderna
MRNA
$25.4B
$44.6M 0.01%
1,073,055
-386,924
-27% -$18.5M
CVCO icon
789
Cavco Industries
CVCO
$4.67B
$44.5M 0.01%
99,651
-5,416
-5% -$2.49M
CR icon
790
Crane Co
CR
$12.7B
$44.3M 0.01%
291,691
-51,972
-15% -$8.58M
MTB icon
791
M&T Bank
MTB
$36.6B
$43.9M 0.01%
233,543
-731
-0.3% -$145K
TBBK icon
792
The Bancorp
TBBK
$2.82B
$43.9M 0.01%
833,452
-64,075
-7% -$3.5M
KGC icon
793
Kinross Gold
KGC
$31.9B
$43.8M 0.01%
4,725,256
-173,902
-4% -$1.71M
UFPT icon
794
UFP Technologies
UFPT
$2.48B
$43.6M 0.01%
178,411
+63,899
+56% +$18.6M
EWBC icon
795
East-West Bancorp
EWBC
$18.6B
$43.6M 0.01%
455,039
-2,037,138
-82% -$200M
BEAM icon
796
Beam Therapeutics
BEAM
$2.74B
$43.5M 0.01%
1,753,142
+266,834
+18% +$6.81M
EIX icon
797
Edison International
EIX
$27.2B
$43.4M 0.01%
543,695
+3,924
+0.7% +$328K
CRH icon
798
CRH
CRH
$65B
$43.3M 0.01%
467,573
-54,346
-10% -$5.23M
SMCI icon
799
Super Micro Computer
SMCI
$25.3B
$43.3M 0.01%
1,419,255
+163,175
+13% +$5.93M
RRC icon
800
CALL
Range Resources
RRC
$9.33B
$43.1M 0.01%
+1,197,597
New +$39.6M

Similar funds

T. Rowe Price Associates's Q4 2024 Portfolio in Review

As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
  • T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
  • T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
  • T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
  • T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
  • T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
  • T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.

Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.